Showing results (21-30 of 307) with videos related to
Sort By:
Pageof 31
Clinical Rheumatology|February 5, 2020
Is the prevention of rheumatoid arthritis possible?Deshiré Alpizar-Rodriguez, Axel FinckhNature Clinical Practice. Rheumatology|January 30, 2008
Primer: strengths and weaknesses of meta-analysisAxel Finckh, Martin R TramèrArthritis Research & Therapy|April 17, 2009
Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical reviewAndrea Rubbert-Roth, Axel FinckhRheumatic Diseases Clinics of North America|December 2, 2014
Prevention of rheumatic diseases: strategies, caveats, and future directionsAxel Finckh, Kevin D DeaneThe Journal of Rheumatology|July 17, 2014
Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?Elena Ciubotariu, Cem Gabay, Axel Finckh, et al.Revue Medicale Suisse|March 15, 2023
[Can we prevent the occurrence of Rheumatoid Arthritis in 2023?]Evangelia Passia, Aline Schläpfer, Axel FinckhRMD Open|February 22, 2020
Measuring ACPA in the general population or primary care: is it useful?Axel Finckh, Delphine Courvoisier, Celine Lamacchia, et al.European Journal of Hospital Pharmacy : Science and Practice|June 22, 2026
A pharmacist-led intervention to promote the uptake of an infliximab biosimilar by patients and physicians in a university hospital rheumatology unitMarion Duwez, Axel Finckh, Pascal BonnabryRevue Medicale Suisse|March 20, 2022
[Vaccine prevention in patients with rheumatic diseases]Axel Finckh, Gilles Eperon, Kim LauperPageof 31